0.6642

3.91% -0.027

Icecure Medical Ltd (ICCM)

Overview News Price History Discussions Forecast Stock Split

Icecure Medical Ltd stock is traded at $0.6642, with a volume of 314.73K. It is down -3.91% in the last 24 hours and down -6.16% over the past month. Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Previous Close:

$0.6912

Open:

$0.68

24h Volume:

314.73K

Relative Volume:

0.29

Market Cap:

$45.81M

Revenue:

$3.67M

Net Income/Loss:

$-13.83M

P/E Ratio:

-2.3721

EPS:

-0.28

Net Cash Flow:

$-10.79M

1W Performance:

-3.23%

1M Performance:

-6.16%

6M Performance:

-32.91%

1Y Performance:

-29.34%

1-Day Range:

$0.6606

$0.70

1-Week Range:

$0.6606

$0.7165

52-Week Range:

$0.59

$1.66

Icecure Medical Ltd Stock (ICCM) Company Profile

Name

Icecure Medical Ltd

Sector

Healthcare (1123)

Industry

Medical Devices (141)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-03-24

Latest SEC Filings

ICCM's Discussions on Twitter

Compare ICCM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ICCM Icecure Medical Ltd	0.6642	47.67M	3.67M	-13.83M	-10.79M	-0.28
ABT Abbott Laboratories	125.46	214.37B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	92.58	136.01B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	354.09	134.98B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	99.87	127.88B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	83.08	48.88B	5.88B	1.34B	799.60M	2.3489

Icecure Medical Ltd Stock (ICCM) Latest News

Dec 10, 2025

IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting - PR Newswire

Dec 10, 2025

Cryoablation: The Minimally Invasive Freezing Technology That's a Game-Changer for Treating Low-Risk, Early-Stage Breast Cancer - Future of Personal Health -

Dec 10, 2025

Dec 09, 2025

IceCure Medical (Nasdaq: ICCM) data show ProSense cuts AWE pain scores to 1 - Stock Titan

Dec 09, 2025

Dec 08, 2025

IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes - marketscreener.com

Dec 08, 2025

Dec 05, 2025

Icecure Receives Notice of Patent Allowance in China for A Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes - marketscreener.com

Dec 05, 2025

Why IceCure Medical Ltd stock remains on buy listsJuly 2025 Movers & Real-Time Volume Analysis Alerts - Newser

Dec 04, 2025

How IceCure Medical Ltd stock benefits from global expansionJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser

Dec 04, 2025

Dec 03, 2025

ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 03, 2025

IceCure Medical schedules special shareholder meeting for January 2026 By Investing.com - Investing.com Canada

Dec 03, 2025

IceCure Medical schedules special shareholder meeting for January 2026 - Investing.com

Dec 03, 2025

IceCure Medical Announces Special General Meeting for Key Votes - TipRanks

Dec 03, 2025

Dec 02, 2025

Icecure Medical (ICCM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga

Dec 02, 2025

Nov 29, 2025

Why retail investors pile into IceCure Medical Ltd stockJuly 2025 Catalysts & Short-Term Swing Trade Alerts - BỘ NỘI VỤ

Nov 29, 2025

Nov 28, 2025

IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances (PR Newswire) - Aktiellt

Nov 28, 2025

Nov 26, 2025